CVE-2017-13681

Description

Symantec Endpoint Protection prior to SEP 12.1 RU6 MP9 could be susceptible to a privilege escalation vulnerability, which is a type of issue that allows a user to gain elevated access to resources that are normally protected at lower access levels. In the circumstances of this issue, the capability of exploit is limited by the need to perform multiple file and directory writes to the local filesystem and as such, is not feasible in a standard drive-by type attack.

7.8
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.09%
Third-Party Advisory securityfocus.com Third-Party Advisory securitytracker.com Third-Party Advisory symantec.com
Affected: Symantec Corporation Symantec Endpoint Protection
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2017-13681?
CVE-2017-13681 has been scored as a high severity vulnerability.
How to fix CVE-2017-13681?
To fix CVE-2017-13681, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-13681 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-13681 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-13681?
CVE-2017-13681 affects Symantec Corporation Symantec Endpoint Protection.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.